SGD has appointed Alain Comel as Chief Financial Officer for its future pharmaceutical group.
He will be responsible for setting up the financial department of the new pharmaceutical entity. Mr Comel will also be part of the Executive Committee and will support the growth’s strategy of the future entity.
Mr Comel (pictured) has been CFO for the past 25 years, out of which more than half spent abroad (Netherlands, UK, Spain, Indonesia and Switzerland). Before joining SGD, Mr Comel was CFO of MeadWestvaco, NY, USA.
SGD said Mr Comel brings expertise in the finance, IT and business development departments.
He holds a Master in Management and a degree in restructuring from the Metz Business School and the law faculty.